drugset / Trial / NCT04160910

5HTP Regulation Of Asthma In Children

NCT04160910

Phase 2 Recruiting 20 enrolled Indiana University
RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this study is to learn more about if taking a supplement called 5-hydroxytryptophan (5HTP) can improve breathing and anxiety symptoms related to asthma. To help learn more subjects will either be assigned to a group that is taking the supplement (5HTP) or a group that is taking a placebo. This will be decided randomly. Later in the study subjects will crossover to the other group.There are 5 study visits over the course of about 12 weeks.

Timeline

Start
2021-02-11
Primary completion
2026-06-30
Completion
2026-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator 5-Hydroxytryptophan Other / unclassified 50 mg
Comparator 5-Hydroxytryptophan Other / unclassified 100 mg

Indications